May 17, 2016   BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in the fields of bone fracture repair, fracture prevention and spinal fusion, today announces positive efficacy results for the second patient cohort in the Phase I/IIA trial of its allogeneic1 bone cell […]